Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across Asia

▴ Quadria Capital Invests $102 Million in NephroPlus
The demand for dialysis services in NephroPlus' targeted markets is projected to surge by more than 11% annually over the next five years.

In a significant move to bolster healthcare services, Singapore-based private equity firm Quadria Capital has announced a substantial investment of $102 million (approximately Rs 850 crore) in NephroPlus, known as Asia’s largest dialysis network. This investment marks a pivotal step in expanding access to high-quality dialysis services across India and other growing markets in Asia.

Quadria Capital will acquire a notable minority stake in NephroPlus through a combination of primary investment and the purchase of shares from existing shareholders, as outlined in a recent company statement. This infusion of capital will empower NephroPlus to meet the escalating demand for reliable and affordable dialysis services in the region.

Established in 2010, NephroPlus has solidified its presence in substantial and high-growth markets across Asia, with a dominant position in India and a rapidly expanding footprint in the Philippines and other Asian countries. The company is poised to leverage this investment to further consolidate its leadership and enhance patient care delivery.

The demand for dialysis services in NephroPlus' targeted markets is projected to surge by more than 11% annually over the next five years, highlighting the critical need for expanded healthcare infrastructure and expertise in renal care.

Vikram Vuppala, the founder and CEO of NephroPlus, expressed enthusiasm about the investment, stating, “Our business has undergone remarkable evolution in recent years, and today we take pride in being one of the fastest-growing and most trusted providers of high-quality dialysis to approximately 30,000 patients. We are committed to expanding our footprint in India, our core market, while exploring new avenues to extend our clinical excellence and expertise to more patients globally.”

This strategic partnership between Quadria Capital and NephroPlus signifies a transformative development in the healthcare landscape, promising enhanced access to critical dialysis services and driving innovation in renal care across Asia.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026